Dogwood Therapeutics Inc.

NASDAQ: DWTX · Real-Time Price · USD
5.29
0.40 (8.18%)
At close: Aug 18, 2025, 3:59 PM
5.36
1.23%
After-hours: Aug 18, 2025, 06:41 PM EDT

Dogwood Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
12.18K n/a n/a n/a
Gross Profit
-12.18K n/a n/a n/a
Operating Income
-12.23M -5.45M -12.32M -15.64M
Interest Income
n/a 150.9K 67.47K 5.67K
Pretax Income
-12.35M -5.3M -12.25M -15.96M
Net Income
-12.35M -5.3M -12.25M -15.96M
Selling & General & Admin
8.7M 3.72M 4.25M 4.85M
Research & Development
3.53M 1.73M 8.07M 10.8M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
12.23M 5.45M 12.32M 15.64M
Interest Expense
92.19K n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
12.23M 5.45M 12.32M 15.64M
Income Tax Expense
-503 n/a n/a n/a
Shares Outstanding (Basic)
1.03M 751.07K 442.8K 333.17K
Shares Outstanding (Diluted)
1.03M 751.07K 442.8K 333.17K
EPS (Basic)
-12.52 -7.05 -27.66 -47.9
EPS (Diluted)
-12.52 -7.05 -27.66 -47.9
EBITDA
-12.25M -5.45M -12.32M -15.64M
EBIT
-12.26M -5.45M -12.32M -15.64M
Depreciation & Amortization
12.18K n/a n/a n/a